Compounds > sulfinpyrazone
Page last updated: 2024-11-04

sulfinpyrazone and Anemia, Hemolytic, Acquired

sulfinpyrazone has been researched along with Anemia, Hemolytic, Acquired in 3 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Owen, J1
Seidenfeld, AM1
Glynn, MF1
Errington, M1
Bloomfield, P1
Woodruff, RK1
Goble, AJ1

Other Studies

3 other studies available for sulfinpyrazone and Anemia, Hemolytic, Acquired

ArticleYear
Amelioration of cardiac hemolytic anemia by sulfinpyrazone therapy.
    Canadian Medical Association journal, 1980, Mar-08, Volume: 122, Issue:5

    Topics: Aged; Anemia, Hemolytic; Anticoagulants; Female; Heart Valve Prosthesis; Humans; Ischemic Attack, Tr

1980
Does sulphinpyrazone reduce haemolysis from prosthetic heart valves?
    Australian and New Zealand journal of medicine, 1992, Volume: 22, Issue:4

    Topics: Aged; Anemia, Hemolytic; Bioprosthesis; Female; Heart Valve Prosthesis; Hemolysis; Humans; Male; Mid

1992
Control of cardiac valve related hemolytic anemia by sulphinpyrazone.
    Australian and New Zealand journal of medicine, 1985, Volume: 15, Issue:5

    Topics: Anemia, Hemolytic; Aortic Valve Stenosis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Sulfinp

1985